Skip to content

Menu

Seyfarth Shaw LLP logo
HomeAboutAuthors
Search
Close

BioLoquitur

The Life Sciences Patent Blog

aBLA

Subscribe to aBLA

Sandoz v. Amgen: The Latest in Biosimilar “Dances”

By Jamaica Szeliga on June 28, 2017
Posted in Biosimilars
shutterstock_511677256

Finding against the Federal Circuit once again on a patent case, the Supreme Court issued a unanimous decision in Sandoz v. Amgen relating to the interpretation of the Biologics Price Competition and Innovation Act of 2009 (“BPCIA”) in its first decision on the Act.  The Supreme Court’s decision firmly establishes the availability of a third…

Stay Connected

RSS Twitter LinkedIn Facebook

Recent Updates

  • Biosimilar IPRs: Timing is Everything . . . But When is The Right Time?
  • Teva Sues FDA Alleging Unlawful Interpretation of the Definition of “First Applicant”
  • USPTO Director Proposes New Patent Eligibility Guidance
  • Tribal Immunity Cannot Be Asserted to Escape IPR Proceedings
  • FDA Approves First Marijuana-Based Drug to Treat Epilepsy

Topics

Archives

Links & Resources

  • ABA Intellectual Property Section
  • American Chemical Society
  • American Intellectual Property Law Association
  • BIO
  • BioCentutry
  • Biospace
  • Biotechnology News — ScienceDaily
  • BioWorld
  • California Peculiarities Employment Law Blog
  • Fierce Biotech
  • Fierce Pharma
  • Genetic Engineering News
  • Patent Trial and Appeal Board (PTAB)
  • Seyfarth PTAB Blog
  • Seyfarth Trade Secrets Blog
  • United States Patent and Trademark Office
Seyfarth Shaw LLP logo
RSS Twitter LinkedIn Facebook
Privacy PolicyAttorney Advertising

About

Seyfarth’s Life Sciences attorneys have a deep understanding of the biotechnology, chemical, pharmaceutical, and nanotechnology industries. We represent an international clientele of innovators and investors working with world-changing technologies. Our clients range from clinical-stage biotechnology companies and multinational pharmaceutical corporations to chemical and nanotechnology companies as well as start-up companies and venture capital firms.

Read More
Copyright © 2022, Seyfarth Shaw LLP. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo